Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation
Haruka Teshigawara-Tanabe(Yokohama City University), Hideaki Nakajima(National Institute of Advanced Industrial Science and Technology), Shin Fujisawa(Yokohama City University Medical Center), Kenji Matsumoto(RIKEN Center for Brain Science), Takayoshi Tachibana(Yokohama City University), Hiroyuki Takahashi(Yokohama City University), Maki Hagihara(Yokohama City University Hospital), Hiroyoshi Kunimoto(Yokohama City University), Heiwa Kanamori(Kanagawa Prefectural Hospital Organization), Satoshi Koyama(Shizuoka Red Cross Hospital), Yuki Nakajima(Fujisawa City Hospital), Jun Aoki(Kanagawa Prefectural Hospital Organization), Takuya Miyazaki(Kanagawa Prefectural Hospital Organization), Masatsugu Tanaka(Kanagawa Prefectural Hospital Organization), Etsuko Yamazaki(Yokohama City University), Masataka Taguri(Yokohama City University)
Cited by 0
Related Papers
Medial prefrontal cell activity signaling prediction errors of action values
|Nature Neuroscience|2007|452
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
|Blood|2008|149
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149